DMK
DMK Pharmaceuticals Corporation Common Stock
Delisted
DMK was delisted on the 6th of February, 2024.
25 hedge funds and large institutions have $179K invested in DMK Pharmaceuticals Corporation Common Stock in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.
Holders
25
Holders Change
+3
Holders Change %
+13.64%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
3
Closed
2
Calls
$75K
Puts
–
Net Calls
+$75K
Net Calls Change
-$188K
Top Buyers
| 1 |
1
Geode Capital Management
Boston,
Massachusetts
|
$37.2K |
| 2 |
2
JPMorgan Chase & Co
New York
|
$23.9K |
| 3 |
TSS
3
Two Sigma Securities
New York
|
$20.5K |
| 4 |
VF
4
Virtu Financial
New York
|
$13K |
| 5 |
TRCT
5
Tower Research Capital (TRC)
New York
|
$16.6K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
FCMT
26
Founders Capital Management (Texas)
Houston,
Texas
| – | – | -71 | Closed |
|
|
FIA
27
FNY Investment Advisers
New York
| – | – | – | – |
|
|
CFGS
28
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
WAS
29
Winch Advisory Services
Appleton,
Wisconsin
| $0 | 1 | – | – |
|
30
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | – | – | – |
|